Butch Jason Insider Trades

Insider Trading History

Track insider trading activity for Butch Jason. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agile Therapeutics
Agile Therapeutics AGRX
Principal Accounting Officer
Holding Value $9.06k 6,000 shares
Last Trade
Nov 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.06M 6,000 shares
$510.75
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Principal Accounting Officer
Holding Value $60.4k 40,000 shares
Last Trade
Jan 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.37B 40,000 shares
$34,200.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Principal Accounting Officer
Holding Value $30.2k 20,000 shares
Last Trade
Mar 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$266M 1,358 shares
$196,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Principal Accounting Officer
Holding Value $28.1k 18,642 shares
Last Trade
Mar 26, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.77B 8,642 shares
$205,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Principal Accounting Officer
Holding Value $37.8k 25,000 shares
Last Trade
Jan 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.05B 25,000 shares
$282,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Principal Accounting Officer
Holding Value $15.1k 10,000 shares
Last Trade
Jan 27, 2021 Sale
$14.1B 50,000 shares
$282,000.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up